|
US5194596A
(en)
|
1989-07-27 |
1993-03-16 |
California Biotechnology Inc. |
Production of vascular endothelial cell growth factor
|
|
FR2650598B1
(fr)
|
1989-08-03 |
1994-06-03 |
Rhone Poulenc Sante |
Derives de l'albumine a fonction therapeutique
|
|
US5350836A
(en)
|
1989-10-12 |
1994-09-27 |
Ohio University |
Growth hormone antagonists
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US6180602B1
(en)
|
1992-08-04 |
2001-01-30 |
Sagami Chemical Research Center |
Human novel cDNA, TGF-beta superfamily protein encoded thereby and the use of immunosuppressive agent
|
|
WO1994003599A1
(fr)
|
1992-08-04 |
1994-02-17 |
Sagami Chemical Research Center |
ADNc HUMAIN ET PROTEINE POUR LAQUELLE CODE CET ADNc
|
|
JPH07258293A
(ja)
|
1994-03-23 |
1995-10-09 |
Asahi Chem Ind Co Ltd |
新規な蛋白質ならびにその製造方法
|
|
AU1830195A
(en)
|
1994-12-15 |
1996-07-03 |
Human Genome Sciences, Inc. |
Prostatic growth factor
|
|
US5994102A
(en)
|
1994-12-15 |
1999-11-30 |
Human Genome Sciences, Inc. |
Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
|
|
US6521227B1
(en)
|
1999-11-18 |
2003-02-18 |
Peter L. Hudson |
Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
|
|
DE69637844D1
(de)
|
1995-06-22 |
2009-04-09 |
St Vincent S Hospital Sidney L |
Neues tgf-beta-ahnliches cytokin
|
|
US6696259B1
(en)
|
1995-11-13 |
2004-02-24 |
Licentia Ltd. |
Assays using glial cell line-derived neurotrophic factor receptors
|
|
NZ324511A
(en)
|
1995-11-13 |
1999-09-29 |
Carlos Ibanez |
Identification and isolation of glial cell line-derived neurotrophic factor receptors (gdnf receptors)
|
|
US6524802B1
(en)
|
1996-03-29 |
2003-02-25 |
The Johns Hopkins University School Of Medicine |
Methods of detecting growth differentiation factor-14
|
|
IL128872A0
(en)
|
1996-09-11 |
2000-01-31 |
Ortho Mcneil Pharm Inc |
TNF-beta-like protein for treating prostate cancer and related nucleic acid molecules pharmaceutical compositions and methods
|
|
EP0981625A2
(en)
|
1997-05-06 |
2000-03-01 |
Human Genome Sciences, Inc. |
$i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES
|
|
NZ501199A
(en)
|
1997-05-22 |
2001-12-21 |
Carlos F |
Glial cell line-derived neurotrophic factor receptors (BDNFR-beta)
|
|
WO1999006445A1
(en)
|
1997-07-31 |
1999-02-11 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-15
|
|
EP1100822A1
(en)
|
1998-07-23 |
2001-05-23 |
Smithkline Beecham Corporation |
Secreted cysteine rich protein-6 (scrp-6)
|
|
AU5994099A
(en)
|
1998-10-01 |
2000-04-26 |
Urmas Arumae |
A novel ret-independent signaling pathway for gdnf
|
|
US6905817B1
(en)
|
1998-10-01 |
2005-06-14 |
Licestia Ltd. |
Ret-independent signaling pathway for GDNF
|
|
US6465181B2
(en)
|
1999-03-25 |
2002-10-15 |
Abbott Laboratories |
Reagents and methods useful for detecting diseases of the prostate
|
|
US6974684B2
(en)
|
2001-08-08 |
2005-12-13 |
Curagen Corporation |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
DE60032355T2
(de)
|
1999-05-17 |
2007-04-26 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Und Zum Vertrieb Von Pharmaka Mbh |
NEUROPROTEKTIVE EIGENSCHAFTEN VON GDF-15, EINEM VERTRETER DER TGF-ß-SUPERFAMILIE
|
|
US6866851B1
(en)
|
1999-12-28 |
2005-03-15 |
Washington University |
GFRα1-RET specific agonists and methods therefor
|
|
CA2405550A1
(en)
|
2000-04-12 |
2001-10-25 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
JP4920851B2
(ja)
|
2000-04-20 |
2012-04-18 |
セイント ヴィンセンツ ホスピタル シドニー リミテッド |
マクロファージ抑制サイトカイン−１（ｍｉｃ−１）が関連する検査方法
|
|
AU2001288770A1
(en)
|
2000-09-08 |
2002-03-22 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
A non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
|
|
WO2002062999A2
(en)
|
2000-12-29 |
2002-08-15 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
|
TW200526779A
(en)
|
2001-02-08 |
2005-08-16 |
Wyeth Corp |
Modified and stabilized GDF propeptides and uses thereof
|
|
WO2002072608A2
(en)
|
2001-03-09 |
2002-09-19 |
University Of Chicago |
POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
|
|
ES2387546T3
(es)
|
2001-05-11 |
2012-09-25 |
Amgen Inc. |
Péptidos y moléculas relacionadas que se unen a TALL-1
|
|
GB0115195D0
(en)
|
2001-06-21 |
2001-08-15 |
Bae Systems Plc |
Split-pin drill jig
|
|
US20030053431A1
(en)
|
2001-09-10 |
2003-03-20 |
Lila Madour |
Method for performing handoff in a radio telecommunications network
|
|
AU2002364586A1
(en)
|
2001-12-21 |
2003-07-30 |
Delta Biotechnology Limited |
Albumin fusion proteins
|
|
US20060253913A1
(en)
|
2001-12-21 |
2006-11-09 |
Yue-Jin Huang |
Production of hSA-linked butyrylcholinesterases in transgenic mammals
|
|
EP1506215B1
(en)
|
2002-03-05 |
2016-11-30 |
Genentech, Inc. |
Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
|
|
US7576185B2
(en)
*
|
2002-03-05 |
2009-08-18 |
Genentech, Inc. |
PRO34128 antibodies
|
|
US20100285016A1
(en)
|
2002-03-05 |
2010-11-11 |
Genentech, Inc. |
PRO34128 nucleic acids
|
|
US7919084B2
(en)
|
2002-06-17 |
2011-04-05 |
St. Vincent's Hospital Sydney Limited |
Methods of diagnosis, prognosis and treatment of cardiovascular disease
|
|
US7157235B2
(en)
|
2002-06-17 |
2007-01-02 |
St. Vincent's Hospital Sydney Limited |
Methods of diagnosis, prognosis and treatment of cardiovascular disease
|
|
CN1241946C
(zh)
|
2002-07-01 |
2006-02-15 |
美国福源集团 |
对多种细胞具刺激增生作用的人血清白蛋白重组融合蛋白
|
|
EP1575512A4
(en)
|
2002-11-08 |
2007-08-29 |
Barnes Jewish Hospital |
METHOD AND COMPOSITIONS FOR THE EPITHELIAL CELL DIFFERENTIATION IN THE PROSTATE
|
|
US7348004B2
(en)
|
2003-05-06 |
2008-03-25 |
Syntonix Pharmaceuticals, Inc. |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
ME01775B
(me)
*
|
2003-11-05 |
2011-02-28 |
Glycart Biotechnology Ag |
Cd20 antitijela sa povećanim afinitetom vezivanja za fc receptor i efektornom funkcijom
|
|
CN1241941C
(zh)
*
|
2003-11-21 |
2006-02-15 |
中国科学院上海生命科学研究院 |
一种促进神经分化和抗细胞凋亡的蛋白质及其编码基因
|
|
ES2555956T3
(es)
|
2004-04-13 |
2016-01-11 |
St Vincent's Hospital Sydney Limited |
Método para modular el apetito
|
|
US20090042780A1
(en)
|
2004-05-20 |
2009-02-12 |
Acceleron Pharma Inc |
Modified TGF-Beta Superfamily Polypeptides and Related Methods
|
|
SI1844337T1
(sl)
|
2005-01-24 |
2013-11-29 |
Pepscan Systems B.V. |
Povezovalne spojine, imunogene spojine in peptidomimetiki
|
|
JP5376948B2
(ja)
*
|
2005-09-13 |
2013-12-25 |
ナショナル リサーチ カウンシル オブ カナダ |
腫瘍細胞活性を調節する方法及び組成物
|
|
HUE067285T2
(hu)
|
2006-03-24 |
2024-10-28 |
Bioverativ Therapeutics Inc |
PC5 mint IX-es faktor propeptidet feldolgozó enzim
|
|
US8974748B2
(en)
|
2007-04-05 |
2015-03-10 |
Corning Incorporated |
Dual inlet microchannel device and method for using same
|
|
CA2649387A1
(en)
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
|
US7754689B2
(en)
|
2006-06-02 |
2010-07-13 |
Wyeth Llc |
Finger-1 peptide analogs of the TGF-β superfamily
|
|
AU2007277556B2
(en)
|
2006-07-26 |
2012-11-29 |
Pepscan Systems B.V. |
Immunogenic compounds and protein mimics
|
|
CA2660691C
(en)
|
2006-08-04 |
2020-01-14 |
Medizinische Hochschule Hannover |
Means and methods for assessing the risk of cardiac interventions based on gdf-15
|
|
AR063494A1
(es)
*
|
2006-10-19 |
2009-01-28 |
Genentech Inc |
Anticuerpos agonistas anti notch3 y su uso en el tratamiento de las enfermedades relacionadas con el gen notch3
|
|
DK2144639T3
(da)
|
2007-04-25 |
2012-12-10 |
Stem Cells Spin S A |
Ny stamcellelinie og anvendelse deraf
|
|
US8067548B2
(en)
|
2007-07-26 |
2011-11-29 |
Novagen Holding Corporation |
Fusion proteins having mutated immunoglobulin hinge region
|
|
WO2009021293A1
(en)
|
2007-08-16 |
2009-02-19 |
St Vincent's Hospital Sydney Limited |
Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity
|
|
JP2011502106A
(ja)
|
2007-10-09 |
2011-01-20 |
セントビンセンツ ホスピタル シドニー リミテッド |
マクロファージ阻害性サイトカイン−１を除去又は不活性化して悪液質を治療する方法
|
|
EP2208072B1
(en)
|
2007-10-22 |
2015-07-01 |
St Vincent's Hospital Sydney Limited |
Methods of prognosis
|
|
PT2235064E
(pt)
|
2008-01-07 |
2016-03-01 |
Amgen Inc |
Método de preparação de moléculas heterodiméricas de fc de anticorpos utilizando efeitos de indução eletrostática
|
|
JP2011509403A
(ja)
|
2008-01-08 |
2011-03-24 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｇｄｆ−１５に基づいて救急室を受診する患者のリスクを評価するための手段及び方法
|
|
EP2242505A4
(en)
|
2008-01-08 |
2012-03-07 |
Biogenerix Ag |
GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES
|
|
US8718994B2
(en)
|
2008-04-09 |
2014-05-06 |
Transtech Pharma, Llc |
Ligands for the GLP-1 receptor and methods for discovery thereof
|
|
WO2009141357A1
(en)
|
2008-05-20 |
2009-11-26 |
Roche Diagnostics Gmbh |
Gdf-15 as biomarker in type 1 diabetes
|
|
JP2011528115A
(ja)
|
2008-07-14 |
2011-11-10 |
エフ．ホフマン−ラ ロシュ アーゲー |
心不全を有する患者の診断、モニター及び治療の選択のためのマルチマーカーパネル
|
|
WO2010019263A2
(en)
|
2008-08-15 |
2010-02-18 |
Genzyme Corporation |
Soluble flt constructs for treating cancers
|
|
MX2011004563A
(es)
|
2008-10-31 |
2011-06-01 |
Centocor Ortho Biotech Inc |
Diferenciacion de celulas madre embrionarias humanas al linaje endocrino pancreatico.
|
|
WO2010048670A1
(en)
|
2008-10-31 |
2010-05-06 |
St Vincent's Hospital Sydney Limited |
Method of prognosis in chronic kidney disease
|
|
EP2209003A1
(en)
|
2009-01-16 |
2010-07-21 |
F. Hoffmann-Roche AG |
Means and methods for differentiating between fibrosis and cirrhosis
|
|
EP2211182A1
(en)
|
2009-01-16 |
2010-07-28 |
Roche Diagnostics GmbH |
Method for the assessment of severity of liver cirrhosis
|
|
WO2010093925A2
(en)
|
2009-02-12 |
2010-08-19 |
Stryker Corporation |
PERIPHERAL ADMINISTRATION OF PROTEINS INCLUDING TGF-β SUPERFAMILY MEMBERS FOR TREATMENT OF SYSTEMIC DISORDERS AND DISEASE
|
|
GB0902737D0
(en)
|
2009-02-19 |
2009-04-01 |
Univ Gent |
GDF15 as a differential marker for spondyloarthropathy
|
|
US8952130B2
(en)
|
2009-02-24 |
2015-02-10 |
The Salk Institute For Biological Studies |
Designer ligands of TGF-β superfamily
|
|
BRPI1011404B1
(pt)
|
2009-05-05 |
2022-05-03 |
Amgen Inc |
Polipeptídeos mutantes fgf21, polipeptídeo de fusão, multímero, composição farmacêutica, ácido nucleico isolado, vetor e célula hospedeira
|
|
AU2010270844A1
(en)
|
2009-07-08 |
2011-12-22 |
Amgen Inc. |
Design of stable and aggregation free antibody Fc molecules through CH3 domain interface engineering
|
|
US20130323835A1
(en)
|
2009-07-15 |
2013-12-05 |
Zirus, Inc. |
Mammalian Genes Involved in Infection
|
|
US20120309697A1
(en)
|
2009-10-28 |
2012-12-06 |
Samuel Norbert Breit |
Methods of diagnosing and prognosing colonic polyps
|
|
TWI600760B
(zh)
|
2009-11-05 |
2017-10-01 |
建南德克公司 |
分泌異源多肽之方法及組合物
|
|
WO2011064758A2
(en)
|
2009-11-30 |
2011-06-03 |
Pfizer Limited |
Fusion protein
|
|
WO2011105573A1
(ja)
|
2010-02-26 |
2011-09-01 |
株式会社未来創薬研究所 |
抗icam3抗体およびその用途
|
|
US9212221B2
(en)
|
2010-03-03 |
2015-12-15 |
Detroit R & D, Inc. |
Form-specific antibodies for NAG-1 (MIC-1, GDF-15), H6D and other TGF-β subfamily and heart disease and cancer diagnoses
|
|
JP5791335B2
(ja)
|
2010-04-07 |
2015-10-07 |
花王株式会社 |
オルガノポリシロキサン化合物の製造方法
|
|
WO2011127458A2
(en)
|
2010-04-09 |
2011-10-13 |
University Of Southern California |
Systems and methods of cell activated, controlled release delivery of growth factors for tissue repair and regeneration
|
|
EP2383571A1
(en)
|
2010-05-02 |
2011-11-02 |
Prof. Hess Medical Consulting GmbH |
Growth differntioation factor 15 (GDF 15) for risk prediction of diabetic foot ulcer
|
|
JP5676763B2
(ja)
|
2010-08-26 |
2015-02-25 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
動脈性高血圧症から心不全への初期移行の評価におけるバイオマーカーの使用
|
|
WO2012047427A2
(en)
*
|
2010-08-31 |
2012-04-12 |
The Regents Of The University Of California |
Antibodies for botulinum neurotoxins
|
|
EP2439535A1
(en)
|
2010-10-07 |
2012-04-11 |
F. Hoffmann-La Roche AG |
Diagnosis of diabetes related heart disease and GDF-15 and Troponin as predictors for the development of type 2 diabetes mellitus
|
|
MX343729B
(es)
|
2011-04-08 |
2016-11-18 |
Amgen Inc |
Factor de diferenciación de crecimiento 15 (gdf-15) y composiciones del mismo para usarse en el tratamiento o mejoramiento de trastornos metabólicos.
|
|
ES2608835T3
(es)
|
2011-04-13 |
2017-04-17 |
Bristol-Myers Squibb Company |
Proteínas de fusión Fc que comprenden nuevos enlazadores o disposiciones
|
|
MX340498B
(es)
|
2011-06-30 |
2016-07-11 |
Chugai Pharmaceutical Co Ltd |
Polipeptido heterodimerizado.
|
|
AU2012275233A1
(en)
|
2011-06-30 |
2013-11-28 |
Genentech, Inc. |
Anti-c-met antibody formulations
|
|
WO2013012648A1
(en)
|
2011-07-15 |
2013-01-24 |
Emory University |
Gdf15 in diagnostic and therapeutic applications
|
|
MX2014009129A
(es)
|
2012-01-26 |
2014-11-21 |
Amgen Inc |
Polipeptidos de factor 15 de diferenciacion de crecimiento (gdf-15).
|
|
EP2830646B1
(en)
|
2012-03-27 |
2018-03-07 |
NGM Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
|
ES2784223T3
(es)
|
2012-06-20 |
2020-09-23 |
Univ Virginia Patent Foundation |
Composiciones y procedimientos para regular la homeostasis de glucosa y la acción de insulina
|
|
WO2014000042A1
(en)
|
2012-06-27 |
2014-01-03 |
Prince Henry's Institute Of Medical Research |
COMPOSITIONS AND METHODS FOR MODIFYING TGF-β FAMILY LIGANDS
|
|
WO2014011955A2
(en)
*
|
2012-07-12 |
2014-01-16 |
Abbvie, Inc. |
Il-1 binding proteins
|
|
WO2014012165A1
(en)
*
|
2012-07-19 |
2014-01-23 |
Alethia Biotherapeutics Inc. |
Anti-siglec-15 antibodies
|
|
MA20150232A1
(fr)
|
2012-08-08 |
2015-07-31 |
Roche Glycart Ag |
Protéines de fusion de l'interleukine-10 et leurs utilisations
|
|
JO3462B1
(ar)
*
|
2012-08-22 |
2020-07-05 |
Regeneron Pharma |
أجسام مضادة بشرية تجاه gfr?3 وطرق لاستخدامها
|
|
EP3590537A1
(en)
|
2012-09-26 |
2020-01-08 |
Julius-Maximilians-Universität Würzburg |
Monoclonal antibodies to growth and differentiation factor 15 (gdf-15)
|
|
US9803014B2
(en)
*
|
2012-10-24 |
2017-10-31 |
Research Development Foundation |
JAM-C antibodies and methods for treatment of cancer
|
|
EP2925358A1
(en)
*
|
2012-12-03 |
2015-10-07 |
Rigshospitalet |
Anti-pad2 antibodies and treatment of autoimmune diseases
|
|
WO2014100689A1
(en)
|
2012-12-21 |
2014-06-26 |
Aveo Pharmaceuticals, Inc. |
Anti-gdf15 antibodies
|
|
DE102013100322A1
(de)
|
2013-01-14 |
2014-07-17 |
Claas Selbstfahrende Erntemaschinen Gmbh |
Schneidwerk
|
|
US9828415B2
(en)
|
2013-01-30 |
2017-11-28 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods of use for treating metabolic disorders
|
|
US9161966B2
(en)
|
2013-01-30 |
2015-10-20 |
Ngm Biopharmaceuticals, Inc. |
GDF15 mutein polypeptides
|
|
WO2014140374A2
(en)
|
2013-03-15 |
2014-09-18 |
Novo Nordisk A/S |
Monovalent cd27 antibodies
|
|
EA035645B1
(ru)
|
2013-03-15 |
2020-07-21 |
Дженентек, Инк. |
ПОЛИПЕПТИДЫ IL-22, ХИМЕРНЫЕ БЕЛКИ IL-22 Fc И ИХ ПРИМЕНЕНИЕ
|
|
US9868777B2
(en)
*
|
2013-06-10 |
2018-01-16 |
Merck Sharp & Dohme Corp. |
CMV neutralizing antigen binding proteins
|
|
US9862752B2
(en)
|
2013-07-31 |
2018-01-09 |
Amgen Inc. |
Growth differentiation factor 15 (GDF-15) constructs
|
|
WO2016014565A2
(en)
*
|
2014-07-21 |
2016-01-28 |
Novartis Ag |
Treatment of cancer using humanized anti-bcma chimeric antigen receptor
|
|
JP6704358B2
(ja)
|
2014-07-30 |
2020-06-03 |
エヌジーエム バイオファーマシューティカルズ インコーポレイテッド |
代謝障害を治療するための組成物および使用方法
|
|
ES2799503T3
(es)
|
2014-10-31 |
2020-12-18 |
Ngm Biopharmaceuticals Inc |
Composiciones y procedimientos de uso para el tratamiento de trastornos metabólicos
|
|
GB201512733D0
(en)
|
2015-07-20 |
2015-08-26 |
Genagon Therapeutics Ab |
Therapeutic agents for treating conditions associated with elevated GDF15
|
|
US11105818B2
(en)
|
2016-01-15 |
2021-08-31 |
Novo Nordisk A/S |
MIC-1 receptor and uses thereof
|
|
CN108697795A
(zh)
|
2016-02-29 |
2018-10-23 |
伊莱利利公司 |
Gfral受体疗法
|
|
CN109069636A
(zh)
*
|
2016-03-04 |
2018-12-21 |
恩格姆生物制药公司 |
用于调节体重的组合物和方法
|
|
JP7021099B2
(ja)
|
2016-03-31 |
2022-02-18 |
エヌジーエム バイオファーマシューティカルス，インコーポレーテッド |
結合タンパク質及びその使用方法
|
|
JP2020503842A
(ja)
|
2016-10-12 |
2020-02-06 |
ヤンセン バイオテツク，インコーポレーテツド |
Ｇｄｆ１５様生物活性の調節因子をスクリーニングするための方法
|
|
KR102715542B1
(ko)
|
2018-08-20 |
2024-10-08 |
화이자 인코포레이티드 |
항-gdf15 항체, 조성물 및 사용 방법
|
|
EP4163300A4
(en)
|
2020-06-04 |
2024-07-03 |
Daegu Gyeongbuk Institute Of Science and Technology |
Gfral-antagonistic antibody and use thereof
|
|
WO2022189936A1
(en)
|
2021-03-08 |
2022-09-15 |
Medimmune, Llc |
Antibodies directed against gdf-15
|
|
BR112023020152A2
(pt)
|
2021-03-31 |
2023-11-14 |
Cambridge Entpr Ltd |
Inibidores terapêuticos de sinalização gdf15
|
|
WO2022207785A1
(en)
|
2021-03-31 |
2022-10-06 |
Kymab Limited |
Antibodies to gfral
|
|
WO2023039359A1
(en)
|
2021-09-10 |
2023-03-16 |
Ngm Biopharmaceuticals, Inc. |
Methods of treating cancer and tumor-related weight loss and cachexia
|